Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

5 Stocks With Crummy Earnings Growth — KWK GNK SOL CRK LM

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Bad Cash Flow — KWK STP ATPG EDN AONE

This week, these five stocks have the worst ratings in Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.

Gold, Gold Stocks Are Tarnished – Sell NOW!

The perfect storm that buoyed gold to near $2,000 has dissipated, and the current situation is weak. Here's why you should bail out of gold and gold stocks now.

5 Stocks to Sell in December

Unlike most large-cap stocks, EBAY, IBM, NTGR, TGT and UTEK are not likely to rally into year-end, making them stocks to sell.

PBR Stock Update – Why Petrobras Is Plummeting

Petrobras unveiled a new pricing formula for its refined products. Unfortunately for PBR stock investors, it lacks transparency and shares have plunged.

5 Stocks With Crummy Sales Growth — NAVB CTEL HKTV CUR IMMU

This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Awful Operating Margin Growth — SYUT CTEL HKTV NYNY IMMU

This week, these five stocks have the worst ratings in Operating Margin Growth, one of the eight Fundamental Categories on Portfolio Grader.

Don’t Buy Orexigen on Diet Pill Hopes

Orexigen Therapeutics joins VIVUS and Arena Pharmaceuticals in an industry that's brought nothing but disappointment to investors: weight-loss drugs.

4 Capital Markets Stocks to Sell Now

The overall ratings of four capital markets stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Medical Devices Stocks to Sell Now

This week, the ratings of three medical devices stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

12 “Triple F” Stocks to Sell

This week, 12 stocks get F's ("strong sell") in Portfolio Grader's three main grading categories, Total Grade, Overall Fundamental Grade, and Quantitative Grade.

5 Stocks With Poor Analyst Earnings Revisions — VCRA SUNE BONT VRTX PSEM

This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

5 Internet and Web Service Stocks to Sell Now

This week, the ratings of five internet and web service stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

17 Oil and Gas Stocks to Sell Now

This week, the overall grades of 17 oil and gas stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Chemicals Stocks to Sell Now

For the current week, the overall ratings of four chemicals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Pharmaceutical Stocks to Sell Now

For the current week, the overall ratings of three pharmaceutical stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Electrical Equipment Stocks to Sell Now

The ratings of five electrical equipment stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Bad Earnings Surprises — WPC CBB ROMA MOD NX

This week, these five stocks have the worst ratings in Earnings Surprises, one of the eight Fundamental Categories on Portfolio Grader.

10 Worst “Strong Sell” Stocks This Week — MCP EGO JCP and more

This week, these ten stocks have the worst year-to-date performance. Each of these also rates an "F" ("strong sell") on Portfolio Grader. Since the beginning of the year, the Nasdaq increased 10.9%, the Dow is up 13.2%, and the S&P has increased 12.1%.